CytomX Therapeutics, Inc. - Common Stock (CTMX)

CUSIP: 23284F105

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+1,466,829
SEC-reported price per share
$2.72
Number of holders
23
Value change
+$3,989,553
Number of buys
16
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
219,759,481

Security key

23284F105

Report period

Q3 2026

Institutions

23

Top holders

10

Ownership snapshot

Top reported holders of CTMX - CytomX Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
13/15
Latest evidence
30 Jun 2026
13F 13D/G Lead comparable stake: 15% 2 rows are not safely comparable across share classes. 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 15%.

13 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 15%
Kynam Capital Management, LP 10%
BlackRock, Inc. 7.6%
Longitude Capital Partners V, LLC 7%
BANK OF AMERICA CORP /DE/ 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F 13D/G
Company
15%
Reported 13D/G · 31 Dec 2025
$122,681,014
32,714,937 shares
— 30 Jun 2026
Kynam Capital Management, LP
13F 13D/G
Company
10%
Reported 13D/G · 30 Jun 2026
$81,386,599
21,703,093 shares
— 30 Jun 2026
BlackRock, Inc.
13F 13D/G
Company
7.6%
Reported 13D/G · 30 Jun 2026
$65,849,333
17,559,822 shares
— 30 Jun 2026
Longitude Capital Partners V, LLC
13D/G
Patrick G. Enright
7%
Reported 13D/G · 31 Mar 2026
$65,740,382
15,288,461 shares
+$16,125,000 31 Mar 2026
BANK OF AMERICA CORP /DE/
13F 13D/G
Company
5.4%
Reported 13D/G · 30 Sep 2026
$56,559,813
15,082,617 shares
— 30 Jun 2026
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
5.4%
Reported 13D/G · 30 Jun 2026
$44,052,135
11,747,236 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
23
Shares
2,698,075
Rows available
23
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
178
Q3 2026 holders
23
Holder diff
-155
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .